Sarah Meibusch News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Best Translational Research Awarded At AusMedtech 2024

Best Translational Research Awarded At AusMedtech 2024
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

South australiaMichelle gallaher ceruleaSarah meibusch oneventuresJoseph ischiaMark lawler west pharmaceuticalsStage innovation forumJiffystent inserterChief executive officerEmergency roomMichelle gallaherTeddie walkerSarah meibuschSteve burnellMark lawlerWest pharmaceuticals

AusMedtechInvest Keynote And Panel Speakers Announced

AusMedtechInvest Keynote And Panel Speakers Announced
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

South australiaAmandeep hansraSarah meibuschAlex romeroFredrik nybergSteve burnellRowena grayRohan grayAdelaide convention centre onBrandon capitalMain sequenceAdelaide convention centreMedical angelsMain sequence venturesManaging directorFounding partner

Best early-stage project at awarded at AusMedtech 2023

miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United kingdomSouth australiaSarah meibusch oneventuresMichelle hillMichelle gallaher opylStage innovation forumBerghofer precision systems biomedicine laboratoryTranslational research at ausmedtechBest translational researchAssociate professor michelle hillProf hillSystems biomedicine laboratoryProteomics clinical applicationsSarah meibuschAshley wittorfJohnson medtech

Axial Therapeutics tops up funding for phase 2 autism trial with $37M series C

Axial Therapeutics has picked up $37.3 million to bankroll a midstage test in autism and fund further work on neurological diseases. The Woburn, Massachusetts-based biotech began the phase 2b study in August and expects primary completion next December.

New south walesUnited statesSarkis mazmanianSeventure nora freyMakoto ohoriSarah meibuschUniversity of tokyo innovation platform companyAxial therapeuticsTokyo innovation platform companyChief scientific officer sarkis mazmanianAxial biotechVenture capitalOngwood founders fundNeurological disorders

Nutromics wins best early-stage project award

Date Time Nutromics wins best early-stage project award Nutromics took home the coverted ‘Best Translational Research’ award at AusMedtech 2021’s Early-Stage Investment Forum, after winning the pitching event judged by an expert investment panel. Nutromics’ Head of Commercial and Intellectual Property Ms Rosie Stramandinoli presented the company’s wearable Continuous Molecular Monitoring (CMM) platform which can measure a wide array of molecular targets continuously and in real time, including drugs, hormones, metabolites, and proteins. This platform technology enables clinicians to receive continuous real-time molecular data to accurately dose a patient and keep them within a narrow therapeutic range. Nutromics’ vision is to create a world with zero preventable deaths due to the lack of timely, molecular-level data.

New zealandRosie stramandinoliKathy connellJamie plattSarah meibuschSteven suchtingBusiness development strategyIp groupStage investment forumTranslational researchBusiness developmentBest translational researchIntellectual property ms rosie stramandinoliContinuous molecular monitoringEarly stage investment forumStrategy manager jamie platt